Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1983 2
1985 1
1986 2
1992 2
1993 1
1996 2
1998 1
2002 1
2003 3
2010 2
2011 1
2012 5
2013 3
2016 1
2019 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Coding table.
Janus TJ. Janus TJ. Continuum (Minneap Minn). 2010 Oct;16(5 Multiple Sclerosis):243-6. doi: 10.1212/01.CON.0000389944.89605.94. Continuum (Minneap Minn). 2010. PMID: 22810611 No abstract available.
Factor XIII (fibrin-stabilizing factor).
Lorand L, Credo RB, Janus TJ. Lorand L, et al. Among authors: janus tj. Methods Enzymol. 1981;80 Pt C:333-41. doi: 10.1016/s0076-6879(81)80029-8. Methods Enzymol. 1981. PMID: 7341914 No abstract available.
Biology and treatment of gliomas.
Janus TJ, Kyritsis AP, Forman AD, Levin VA. Janus TJ, et al. Ann Oncol. 1992 Jun;3(6):423-33. doi: 10.1093/oxfordjournals.annonc.a058228. Ann Oncol. 1992. PMID: 1498059 Review.
Vision for a digital future: getting personal.
Janus TJ. Janus TJ. Neurology. 2012 Mar 27;78(13):1029; author reply 1029. doi: 10.1212/01.wnl.0000413427.91173.28. Neurology. 2012. PMID: 22454271 Free PMC article. No abstract available.
Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial.
Coles AJ, Twyman CL, Arnold DL, Cohen JA, Confavreux C, Fox EJ, Hartung HP, Havrdova E, Selmaj KW, Weiner HL, Miller T, Fisher E, Sandbrink R, Lake SL, Margolin DH, Oyuela P, Panzara MA, Compston DA; CARE-MS II investigators. Coles AJ, et al. Lancet. 2012 Nov 24;380(9856):1829-39. doi: 10.1016/S0140-6736(12)61768-1. Epub 2012 Nov 1. Lancet. 2012. PMID: 23122650 Clinical Trial.
28 results